A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy - Maruyama, T; Fujisawa, T; Ishida, T (Clin Infect Dis, 2018)
, et al.